Trxade, Inc (MEDS) Corporate Media Kit

16 NASDAQ: MEDS • Key Takeaways (NASDAQ: MEDS) TRxADE is a technology and services company focused on a more effective process for purchasing and delivering prescription drugs to independent pharmacists and consumers. A Tech-Enabled Pharmaceutical Supply Chain Marketplace • Market Leader: Operates the largest technology platform serving the pharmaceutical supply chain (similar to an eBay or Kayak-style platform) • Innovator: Significantly lowering drug costs via a proprietary technology platform • Built-Out Platform: Platform development requires minimal capital investment on a go-forward basis • Expansion: Further expansion to address new market opportunities to leverage TRxADE’s industry expertise & network of 11,700+ independent pharmacy partners • Profitable: Positive operating profits in 9 of the last 11 quarters with tech-like margins • Rapidly Growing: Grew revenues 94% in 2019 with over 3,200 new pharmacy users • Robust Balance Sheet: $4.2 million in cash with limited debt • Experienced Management: Management and Directors own ~54% of shares outstanding Annual Revenue Growth (USD $ in Thousands) $806 $956 $1,496 $4,992 $2,482 $2,931 $3,832 $7,436 2012 2013 2014 2015 2016 2017 2018 2019